Sex Influence on Heart Failure Prognosis

Andrea Postigo1,2,3,4, Manuel Martínez-Sellés1,2,3,4,5

  • 1Servicio de Cardiología, Hospital General Universitario Gregorio Marañón, Madrid, Spain.

Insights

Women with heart failure (HF) experience worse symptoms but have a better prognosis than men. This review explores sex-related differences in HF, aiming to explain women's survival advantage despite less treatment.

Area of Science:

  • Cardiology
  • Sex-based Medicine

Background:

  • Heart failure (HF) affects 1-2% of developed populations, with women comprising ~50% of patients.
  • Women with HF are often older and present with hypertension, valvular heart disease, and non-ischemic cardiomyopathy.
  • Limited prospective HF studies on women necessitate inferences from male-centric trials and registries.

Purpose of the Study:

  • To describe sex-related differences in heart failure (HF).
  • To explore how these differences may explain the better prognosis observed in women with HF compared to men.

Main Methods:

  • Review of existing literature and clinical trial data focusing on sex-based differences in HF.
  • Analysis of patient demographics, comorbidities, clinical presentation, treatment patterns, and outcomes.

Main Results:

  • Women exhibit greater clinical severity, more symptoms, and worse functional class in HF.
  • Despite lower receipt of guideline-proven HF therapies, women demonstrate a survival advantage over men.
  • Potential contributing factors to female survival, such as prior pregnancies, are considered.

Conclusions:

  • Significant sex-related differences exist in heart failure (HF) regarding age, etiology, comorbidities, and clinical presentation.
  • Women with HF have a better prognosis than men, a phenomenon not fully explained by current understanding or treatment disparities.
  • Further research is needed to elucidate the biological and clinical factors, including potential roles of prior pregnancies, contributing to women's improved HF survival.

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...